Cargando…

Treatment in advanced colorectal cancer: what, when and how?

Treatment of advanced colorectal cancer (CRC) increasingly requires a multidisciplinary approach and multiple treatment options add to the complexity of clinical decision-making. Recently novel targeted therapy against angiogenesis and epidermal growth factor receptor completed a plethora of phase I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chau, I, Cunningham, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695695/ https://www.ncbi.nlm.nih.gov/pubmed/19436303 http://dx.doi.org/10.1038/sj.bjc.6605061

Ejemplares similares

Colorectal Cancer Screening—Who, How, and When?
por: Bevan, Roisin, et al.
Publicado: (2018)

Immunotherapy in Breast Cancer: When, How, and What Challenges?
por: Henriques, Beatriz, et al.
Publicado: (2021)

Citrate: How to Get Started and What, When, and How to Monitor?
por: Honore, Patrick M., et al.
Publicado: (2018)

What? When? And How?
por: Hutchinson, Jonathan
Publicado: (1890)

Fungal Genomics in Respiratory Medicine: What, How and When?
por: Brackin, Amelie P., et al.
Publicado: (2021)

Treatment strategies in axial spondyloarthritis: what, when and how?
por: Fragoulis, George E, et al.
Publicado: (2020)

Immune Monitoring upon Treatment with Biologics in Sjögren’s Syndrome: The What, Where, When, and How
por: van Beers, Joyce J.B.C., et al.
Publicado: (2021)

Surveillance in testicular cancer: who, when, what and how?
por: Sohaib, S.A., et al.
Publicado: (2007)

The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine
por: Dirks, Niek F., et al.
Publicado: (2018)

What, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease
por: Przybyl, Lukasz, et al.
Publicado: (2021)

Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
por: Deligne, Claire, et al.
Publicado: (2022)

Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy
por: Chau, I, et al.
Publicado: (2004)

Advancing Teams Research: What, When, and How to Measure Team Dynamics Over Time
por: Delice, Fabrice, et al.
Publicado: (2019)

What to Eat, and What to Drink, and How, and When, and Where to Do It
por: Pratt, B. H.
Publicado: (1869)

External validation of prognostic models: what, why, how, when and where?
por: Ramspek, Chava L, et al.
Publicado: (2020)

Iron supplementation in the intensive care unit: when, how much, and by what route?
por: Lapointe, Marc
Publicado: (2004)

Plasticity within the αβ(+)CD4(+) T-cell lineage: when, how and what for?
por: Coomes, Stephanie M., et al.
Publicado: (2013)

Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want?
por: Mandelblatt, Jeanne, et al.
Publicado: (2003)

Pain in Colorectal Surgery: How Does It Occur and What Tools Do We Have for Treatment?
por: Ivascu, Robert, et al.
Publicado: (2023)

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
por: Chau, I, et al.
Publicado: (2001)

Palliative care in intensive care units: why, where, what, who, when, how
por: Mercadante, Sebastiano, et al.
Publicado: (2018)

Joint aspiration for diagnosis of chronic periprosthetic joint infection: when, how, and what tests?
por: Quinlan, Nicole Durig, et al.
Publicado: (2023)

The Choice Between Advanced Therapies for Parkinson’s Disease Patients: Why, What, and When?
por: Dijk, Joke M., et al.
Publicado: (2020)

Treatment of Gingival Recession: When and How?
por: Imber, Jean-Claude, et al.
Publicado: (2021)

The Role of Words in Cognitive Tasks: What, When, and How?
por: Robinson, Christopher W., et al.
Publicado: (2012)

Imaging for Plasma Cell Dyscrasias: What, When, and How?
por: Guha, Amrita, et al.
Publicado: (2022)

Cancer-associated thrombosis: the when, how and why
por: Fernandes, Caio J., et al.
Publicado: (2019)

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?
por: Falco, Michał, et al.
Publicado: (2023)

How to decide: what to do when you don't know what to do
por: Herring, Jonathan
Publicado: (2012)

A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States – How, what and when?
por: Davis, Melinda M., et al.
Publicado: (2018)

Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?
por: Kumarasamy, N., et al.
Publicado: (2011)

Establishing a clinical service to prevent psychosis: What, how and when? Systematic review
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2021)

Optimizing biologic treatment in IBD: objective measures, but when, how and how often?
por: Ben-Horin, Shomron, et al.
Publicado: (2015)

Why, what, who, when and how? Hand hygiene measured in India?
por: Hemalatha, J, et al.
Publicado: (2015)

How Far Will Clinical Application of AI Applications Advance for Colorectal Cancer Diagnosis?
por: Mori, Yuichi, et al.
Publicado: (2020)

How the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor
por: Ho, Teresa, et al.
Publicado: (2019)

A tutorial on methodological studies: the what, when, how and why
por: Mbuagbaw, Lawrence, et al.
Publicado: (2020)

Economic evaluation of biosimilars for reimbursement purposes – what, when, how?
por: Moorkens, Evelien, et al.
Publicado: (2020)

To Treat or Not to Treat? Dilemmas when Deciding on Antineoplastic Treatment in Patients With Far Advanced Cancers
por: Paiva, Carlos Eduardo, et al.
Publicado: (2023)

Chemokines—What Is Their Role in Colorectal Cancer?
por: Pączek, Sara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o0vetp6f7do2h1q1dbbpc0r2h9